These are the stocks posting the largest moves before the bell.Market Insiderread more
The Federal Reserve's expected interest rate cuts appears to have impacted J.P. Morgan's forecast for 2019 net interest income.Financeread more
Credit card sales volume rose 11% this quarter and merchant processing volume increased 12%, the bank says in its earnings statement.Banksread more
EU Competition Commissioner Margrethe Vestager is preparing to launch a full probe into Amazon in the coming days, Bloomberg reported.Technologyread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
GE hasn't had a year this good during this millennium. After that massive surge, one trader is warning investors to stay away.Trading Nationread more
KeyCorp said in an 8-K filing the fraud involves a "business customer" and was discovered "on or about" July 9.Banksread more
Domino's Pizza stock fell Tuesday after reporting disappointing sales, despite beating Wall Street's earnings estimates.Restaurantsread more
CNBC Make It set out to find the schools that provide middle-class American students the highest average salaries for their tuition dollars.Definitive Guide to Collegeread more
Facebook needs to address the anti-competitive behaviors of its digital coin, Kevin McCarthy says.Politicsread more
U.S. retail sales increased more than expected in June, pointing to strong consumer spending.Economyread more
Oscar Schafer, chairman of Rivulet Capital, is making a bet that shares of a small-cap biotech company will rally on the back of stronger earnings and sound fundamentals.
The value investor decided to add shares of ANI Pharmaceuticals to his "Squawk Box" model portfolio, in a move he hopes will catapult him to the top spot in the competition.
So far this year, Schafer's portfolio is up 11 percent compared with a return of 2.4 percent for the .
Here's how he's managed to beat the market this year.